A low-cost, programmable device for versatile current delivery in iontophoresis applications

Abstract Iontophoresis for the localised delivery of drugs through skin or for non-invasive, remote monitoring of patients by extraction of blood-borne components through skin could allow a new generation of medical devices to be developed for low-cost healthcare. Iontophoresis systems in existence today are generally not very portable and too expensive for all world markets. Accordingly, a low-cost, low-power, miniature and programmable device was developed and evaluated which can be programmed to deliver various current profiles during iontophoresis. It can provide a range of current (1–300 μA) of various signal waveforms (dc, pulsed dc, bipolar dc and pulsed bipolar dc) of the type required for iontophoresis. Evaluation showed that this device provides for precise regulation of the magnitude and waveform of a current. The current can be maintained over a wide range of impedance, important for use in medical application, and is independent of the battery voltage.

[1]  K. Sugibayashi,et al.  Non-invasive sampling of lactic acid ions by iontophoresis using chloride ion in the body as an internal standard. , 1993, Journal of Pharmaceutical and Biomedical Analysis.

[2]  Richard H. Guy,et al.  Reverse Iontophoresis: Development of a Noninvasive Approach for Glucose Monitoring , 1993, Pharmaceutical Research.

[3]  C. Bieglmayer,et al.  NEW TREATMENT OF ATROPHIC ACNE SCARS BY IONTOPHORESIS WITH ESTRIOL AND TRETINOIN , 1995, International journal of dermatology.

[4]  T. Yamamoto,et al.  Electrical properties of the epidermal stratum corneum. , 1973, Medical & biological engineering.

[5]  E. A. D. Felice.  CRANIAL ELECTROTHERAPY STIMULATION (CES) IN THE TREATMENT OF ANXIETY AND OTHER STRESS-RELATED DISORDERS: A REVIEW OF CONTROLLED CLINICAL TRIALS , 1997 .

[6]  A. J. Robinson,et al.  Transcutaneous electrical nerve stimulation for the control of pain in musculoskeletal disorders. , 1996, The Journal of orthopaedic and sports physical therapy.

[7]  R. Guy,et al.  Reverse Iontophoresis: Noninvasive Glucose Monitoring in Vivo in Humans , 1995, Pharmaceutical Research.

[8]  A S Lichtbroun,et al.  The Treatment of Fibromyalgia with Cranial Electrotherapy Stimulation , 2001, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[9]  R. Guy,et al.  In vitro and in vivo iontophoresis of a tripeptide across nude rat skin , 1992 .

[10]  P. Connolly,et al.  Opportunities at the skin interface for continuous patient monitoring: a reverse iontophoresis model tested on lactate and glucose. , 2002, IEEE transactions on nanobioscience.

[11]  I. Nofroni,et al.  Suppression of pelvic pain during hysteroscopy with a transcutaneous electrical nerve stimulation device. , 2003, Fertility and sterility.

[12]  L. Jovanovic,et al.  Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. , 1999, JAMA.

[13]  F. Benedetti,et al.  Control of postoperative pain by transcutaneous electrical nerve stimulation after thoracic operations. , 1997, The Annals of thoracic surgery.

[14]  R. Potts,et al.  Glucose monitoring by reverse iontophoresis , 2002, Diabetes/metabolism research and reviews.

[15]  R O Potts,et al.  Clinical evaluation of the GlucoWatch biographer: a continual, non-invasive glucose monitor for patients with diabetes. , 2001, Biosensors & bioelectronics.

[16]  R O Potts,et al.  Detection of hypoglycemia with the GlucoWatch biographer. , 2001, Diabetes care.

[17]  R H Guy,et al.  Transdermal therapy and diagnosis by iontophoresis. , 1997, Trends in biotechnology.

[18]  J. Marshall,et al.  The use of cranial electrotherapy stimulation in the treatment of closed-head-injured patients. , 1994, Brain injury.

[19]  R. Guy,et al.  Noninvasive sampling of phenylalanine by reverse iontophoresis. , 1999, Journal of controlled release : official journal of the Controlled Release Society.